generated: '2026-08-25' method: probed source: >- https://memo-therapeutics.com (site walk on 2026-08-25) and the live route index at https://memo-therapeutics.com/wp-json/ summary: >- Memo Therapeutics publishes no API lifecycle policy of any kind. There is no changelog, no status page, no deprecation or sunset policy, no SLA and no support channel for this surface, because the surface is a side effect of the company's WordPress marketing site rather than a product. What follows records those absences with the probe that established each one. versioning: scheme: namespace-in-path current: wp/v2 discovery: GET https://memo-therapeutics.com/wp-json/ policy_published: false note: >- Version changes arrive whenever WordPress core is upgraded on this deployment. No advance notice, no version negotiation, no parallel-version window is offered or promised. deprecation: policy_published: false sunset_header: false deprecation_header: false rfc8594: false deprecated_operations: [] note: >- No RFC 8594 Sunset or Deprecation header appeared on any observed response, and no page on memo-therapeutics.com states a deprecation policy. No Deprecation pointer is emitted in apis.yml. status_page: published: false probed: - url: https://status.memo-therapeutics.com/ status: 'no TLS certificate for the host (wildcard DNS only)' note: >- memo-therapeutics.com resolves every subdomain to 185.151.30.220 by wildcard, and status., api., docs., developer., app. and portal. all fail TLS with "no alternative certificate subject name matches target host name". There is no status page. No StatusPage pointer is emitted in apis.yml. sla: published: false support: developer_channel: false general_contact: https://memo-therapeutics.com/contact-us/ emails: - corporate.communications@ipsen.com - info@memo-therapeutics.com note: >- The contact route is corporate communications, not developer support. Since the Ipsen acquisition closed on 2026-07-22 the site header directs enquiries to corporate.communications@ipsen.com. corporate_lifecycle: event: acquisition acquirer: Ipsen (Euronext IPN, ADR IPSEY) completed: '2026-07-22' evidence: https://memo-therapeutics.com/2026/07/22/ipsen-completes-acquisition-of-memo-therapeutics-ag-adding-first-in-class-asset-to-ipsens-rare-disease-pipeline/ observable_effects: - The site now brands itself "Memo Therapeutics AG, an Ipsen company" and serves a memo-therapeutics-ipsen lock-up logo added to the media library. - https://memo-therapeutics.com/careers/ 302s to https://www.ipsen.com/careers/ — the careers surface has already been folded into the parent. - Contact enquiries are routed to corporate.communications@ipsen.com. note: >- The content API is the surface most likely to disappear first if the site is consolidated into ipsen.com. Anything built on it should treat it as unversioned and unpromised.